Use of chemotherapeutic agents
a chemotherapeutic agent and a technology for chemotherapy, applied in the direction of drug compositions, aerosol delivery, metabolic disorders, etc., can solve the problems of residual microorganisms being left behind, risk of false diagnosis, and inconsistent clinical pictures, and achieve rapid bactericidal action, good local tolerability, and high activity
Inactive Publication Date: 2010-12-30
BAYER INNOVATION GMBH
View PDF17 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
[0018]Accordingly, given the current state of the art, there is also a need in human and veterinary medicine for topically and / or locally applicable agents with an antibiotic action which have a high activity against the microbes occurring in wounds, have a rapid bactericidal action, have a good local tolerability, elicit a low tendency to generate antibiotic resistance, are easy to administer by topical and / or local application, place a minimum systemic burden on the organism when administered topically / locally, have a good tissue penetration, are also suitable for the treatment of deep infections and additionally accelerate the wound healing process.
Problems solved by technology
The particular problems associated with treatment of the pulp are the small lymph supply, its position as a terminal organ with a small collateral circulation, and the influence of external stimuli given its location in a rigid, inflexible cavity.
The particular problem associated with the diagnosis of a pulp disease is that the histological and clinical pictures are often quite different.
As pain is sensed and interpreted differently by different patients, there is always the risk of a false diagnosis.
Under the conventional treatment, there is then the danger of residual microbes being left behind.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
example 1
[0110]
Moxifloxacin HCl solutionmoxifloxacin hydrochloride500 mgaqua pro injectionead 100 ml
example 2
[0111]
High-viscosity formulation: moxifloxacin HCl gelmoxifloxacin hydrochloride 1.0 ghydroxyethyl cellulose 0.5 gpropylene glycol 1.5 gdistilled water ad10.0 g
example 3
[0112]
Low-viscosity formulation with stabilizer: moxifloxacin — HCl gelmoxifloxacin hydrochloride1.0 ghydroxyethyl cellulose0.25 g propylene glycol1.5 g1% Tween 20 solution1.0 gdistilled water ad10.0 g
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Property | Measurement | Unit |
---|---|---|
concentration | aaaaa | aaaaa |
concentrations | aaaaa | aaaaa |
concentrations | aaaaa | aaaaa |
Login to view more
Abstract
The use of chemotherapeutic agents for the preparation of a medicament for the topical and/or local treatment of diseases caused by bacteria and/or for prophylaxis in humans or animals.
Description
CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application is a divisional application of U.S. patent application Ser. No. 10 / 168,441, filed on Jun. 21, 2002, which was filed under International Application No. PCT / EP00 / 13155 filed Dec. 22, 2000, which claims priority to German Patent Application 199 62 470.4 filed Dec. 22, 1999 (the entire disclosures of which are incorporated herein by reference).BACKGROUND OF THE INVENTION[0002]1. Field of the Invention[0003]The present invention relates to the use of chemotherapeutic agents for the preparation of a medicament for the topical and / or local treatment of diseases caused by bacteria and / or for prophylaxis in humans or animals.[0004]2. Description of Related Art[0005]Bacteria can be the cause of a large number of diseases and can moreover impair wound healing. In the oral region, for example, tooth decay (caries) is caused by microbes specific to the mouth. Oral bacteria convert dietary carbohydrates to acids capable of dissolving ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K9/127A61K31/437A61P29/00A61P43/00A61F13/20C07D471/04A61K9/06A61K9/08A61K9/10A61K9/107A61K9/14A61K31/00A61K31/47A61K31/4709A61K31/4745A61K47/10A61K47/14A61K47/26A61K47/34A61K47/38A61L15/44A61P1/02A61P3/10A61P17/02A61P31/04
CPCA61K9/0014A61K31/47A61K31/4709A61K31/4745A61K47/10Y10S514/902A61K47/38A61K31/4375A61K31/496A61K31/5383Y10S514/90A61K47/26A61K6/69A61K6/54A61P1/00A61P1/02A61P17/02A61P17/10A61P29/00A61P3/10A61P31/00A61P31/02A61P31/04A61P43/00
Inventor SCHULZ, HANS-HERRMANNSCHLIMBACH, GUNTHER
Owner BAYER INNOVATION GMBH
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap